Guoying Wang
8PUBLICATIONS
23CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Feb 21, 2025
Activation of gut FXR improves the metabolism of bile acids, intestinal barrier, and microbiota under cholestatic condition caused by GCDCA in mice.Xing-Ming Xie, Bang-Yan Zhang, Shu Feng
|May 08, 2024
Regorafenib with immunotherapy versus regorafenib alone as second-line treatment for hepatocellular carcinoma: A multicenter real-world study.Liang Qiao, Wei He, Guoying Wang
|Apr 10, 2023
Identification and Experimental Validation of the Prognostic Significance and Immunological Correlation of Glycosylation-Related Signature and ST6GALNAC4 in Hepatocellular Carcinoma.Tianxing Dai, Jing Li, Run-Bin Liang
|Oct 28, 2022
Upregulation of TMCO3 Promoting Tumor Progression and Contributing to the Poor Prognosis of Hepatocellular Carcinoma.Tianxing Dai, Linsen Ye, Mingbin Deng
|May 09, 2022
Prognostic Role and Potential Mechanisms of N6-methyladenosine-related Long Noncoding RNAs in Hepatocellular Carcinoma.Tianxing Dai, Jing Li, Linsen Ye
Pageof 2